Red Tree Management, LLC

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed April 22, 2026), Red Tree Management, LLC reported 3 stock positions worth $111.8 million. Its top holding was Bicara Therapeutics (BCAX) at 56.4% of the portfolio, followed by Ceribell (CBLL, 36.2%) and Contineum Therapeutics Class A (CTNM, 7.5%). Its holdings were unchanged from Q4 2025.

Most Recent 13F
Q2 2026
Location
REDWOOD CITY, CA
CIK
0002055980
Portfolio Value
$111.8M (Q1 2026)
SEC Filing
0002055980-26-000006 ↗ filed Apr 22, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q4 2024: $152.0M Q4 2024 Q1 2025: $92.6M Q1 2025 Q2 2025: $73.3M Q2 2025 Q3 2025: $82.9M Q3 2025 Q4 2025: $109.0M Q4 2025 Q1 2026: $111.8M $111.8M Q1 2026 Q2 2026: $147.3M Q2 2026

Holdings 3 stocks · $111.8M
BCAX Bicara Therapeutics Inc. 56.39% 3,170,509 $63.1M No change
CBLL Ceribell Inc. 36.15% 2,205,661 $40.4M No change
CTNM Contineum Therapeutics Inc. Class A 7.45% 638,158 $8.3M No change

Portfolio Sells Q4 2025 → Q1 2026
None this quarter.

Portfolio Buys Q4 2025 → Q1 2026
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$147.3MBCAX, CBLL, CTNM
Q1 2026 3$111.8MBCAX, CBLL, CTNM
Q4 2025 3$109.0MBCAX, CBLL, CTNM
Q3 2025 3$82.9MBCAX, CBLL, CTNM
Q2 2025 3$73.3MCBLL, BCAX, CTNM
Q1 2025 4$92.6MCBLL, BCAX, CRGX, CTNM
Q4 2024 4$152.0MCBLL, BCAX, CRGX, CTNM